Mutagenicity

EU Commission Requests ECHA Opinion On BCDMH Mutagenicity For Biocidal Product-Types 2, 11 And 12

The European Commission has asked ECHA’s Biocidal Products Committee to re-open its assessment of the active substance BCDMH for biocidal product-types 2, 11 and 12 by defining specific mutagenicity studies, allowing the applicant to submit new data, and revising earlier opinions that recommended non-approval due to a data gap. This re-evaluation could change whether BCDMH-based biocidal products can ultimately be approved in the EU, so active substance holders and formulators should closely track the new testing requirements, data deadlines, and any revised scientific opinions.

23 May 2026, 08:58echa.europa.euEuropean Union

Netherlands RIVM Publishes Framework To Prioritise Substances For Health-Based Workplace Exposure Limits

In May 2026, RIVM published a framework and priority list of 49 groups of carcinogenic, mutagenic and reproduction-toxic substances for which the Dutch Health Council may develop health-based workplace exposure limits. This signals which chemicals are most likely to face early attention in future Dutch occupational exposure limit proposals, helping companies anticipate stricter controls, data needs and potential SZW limit-setting.

21 May 2026, 12:20rivm.nlNetherlands

OECD Opens First Commenting Round On Draft DRP For In Vitro Mammalian Cell Genotoxicity Methods (γH2AX, pH3)

The OECD has opened a public consultation from 15 May to 26 June 2026 on a draft Detailed Review Paper assessing in vitro mammalian cell genotoxicity assays based on the γH2AX and pH3 phosphorylated histone biomarkers. This review sits within the OECD Test Guidelines Programme and may shape future genotoxicity test guidelines, so companies relying on in vitro genotoxicity testing should track its outcomes and consider providing input via their National Coordinators.

20 May 2026, 07:09oecd.orgGlobal

ECHA REACH Compliance Check: Valeraldehyde Moves to Follow-Up Stage

ECHA has moved the EU REACH compliance check for Valeraldehyde into the follow-up phase after the 4 May 2026 deadline for submitting additional mutagenicity and aquatic toxicity data. This indicates that registrants’ dossiers are now under active scrutiny and that any gaps in required in vivo studies or dossier updates could escalate to national enforcement, so companies using or registering Valeraldehyde should verify compliance urgently.

14 May 2026, 09:26echa.europa.euEuropean Union

Nebraska Legislature Indefinitely Postpones LB831 on Ethylene Oxide Civil Actions

Nebraska’s LB831, a bill to establish limitations and requirements for civil actions related to ethylene oxide exposure, was indefinitely postponed by the Legislature on 17 April 2026, ending its progress this session. For operators with ethylene oxide risk in Nebraska, there are no new statutory liability shields or constraints on lawsuits, so existing tort and exposure-control regimes continue to apply while political scrutiny of ethylene oxide remains elevated.

9 May 2026, 13:37nebraskalegislature.govUnited States

ECHA Opens CLH Consultation on Metaldehyde (EC 203-600-2, CAS 108-62-3)

ECHA has launched an EU CLP public consultation on a proposed harmonised classification for the substance metaldehyde, open for comments from 4 May to 3 July 2026. The eventual CLH outcome will fix a uniform EU hazard profile for metaldehyde, shaping how manufacturers and downstream users classify, label, and communicate its risks across products and supply chains.

7 May 2026, 07:47echa.europa.euEuropean Union

ECHA RAC Adopts CLH Opinion on Potassium Bromate Under CLP

ECHA’s Committee for Risk Assessment has adopted its opinion on the harmonised classification of potassium bromate under the CLP Regulation, with the CLH registry now showing status "Opinion Adopted" based on a March 2026 opinion and an April 2026 update. This scientific step signals a likely future CLP Annex VI amendment, so EU companies handling potassium bromate should anticipate stricter carcinogenicity, mutagenicity and acute toxicity classification and start preparing for potential labelling, SDS and risk‑management changes once an ATP is proposed.

3 May 2026, 09:18echa.europa.euEuropean UnionGermany

ECHA Invites Information on In Vivo Genetic Toxicity Testing Proposal for Dilithium Adipate

In April 2026, ECHA opened a REACH testing proposal consultation on in vivo genetic toxicity (endpoint 7.6.2) for Dilithium adipate, inviting third-party information with submissions due by 12 June 2026. The outcome will shape how registrants meet REACH information requirements for Dilithium adipate and related Dilithium sebacate, and may signal closer regulatory scrutiny of their mutagenicity profiles.

3 May 2026, 09:13echa.europa.euEuropean Union

ECHA Opens REACH Testing Proposal Consultation For N,N-Dicyclohexylbenzothiazole-2-Sulphenamide (CAS 4979-32-2)

ECHA has opened a REACH testing proposal consultation on N,N-dicyclohexylbenzothiazole-2-sulphenamide (CAS 4979-32-2), seeking data on in vivo genetic and developmental toxicity with comments due by 12 June 2026. The resulting vertebrate studies and third-party evidence could materially influence future hazard classification and risk management for this substance, so EU registrants and downstream users should monitor outcomes and consider contributing relevant information.

3 May 2026, 07:37echa.europa.euEuropean Union

ECHA Consultation on REACH Testing Proposals for N-cyclohexylbenzothiazole-2-sulfenamide (CAS 95-33-0)

ECHA is consulting on REACH testing proposals for N-cyclohexylbenzothiazole-2-sulfenamide (EC 202-411-2, CAS 95-33-0), covering bioaccumulation, repeated-dose oral toxicity, in vivo genetic toxicity and reproductive toxicity, with comments due by 12 June 2026. The outcome will determine whether new vertebrate studies are required for this substance and structurally related analogues, influencing future hazard data, classification decisions and REACH compliance planning.

3 May 2026, 07:34echa.europa.euEuropean Union

ECHA Invites Information on In Vivo Genetic Toxicity Testing Proposal for Trientine (CAS 112-24-3)

In April 2026 ECHA opened a REACH testing proposal consultation on an in vivo genetic toxicity study for Trientine (EC 203-950-6; CAS 112-24-3), with third-party information due by 12 June 2026. Companies manufacturing, importing, or using Trientine should review and submit any existing relevant data, as the outcome may influence REACH information requirements and future regulatory scrutiny of this substance.

3 May 2026, 07:32echa.europa.euEuropean Union

ECHA Opens REACH Testing Proposal Consultation For Bis(4-isopropylphenyl)iodonium Tetraphenylborate

ECHA has opened a REACH testing proposal consultation on in vivo genetic toxicity (endpoint 7.6.2) for Bis(4-isopropylphenyl)iodonium tetraphenylborate (EC 679-512-7; CAS 1158840-74-4), with comments due by 12 June 2026. This may lead to additional vertebrate testing and inform future hazard classification, so registrants and affected supply chains should assess available data and decide whether to submit scientifically robust evidence.

3 May 2026, 07:31echa.europa.euEuropean Union

HEAL Letter to EP ENVI and IMCO on Omnibus VI Cosmetics Vote

A March 2026 letter from the Health and Environment Alliance urges MEPs on the ENVI and IMCO committees to oppose Omnibus VI amendments that would extend phase-out deadlines for carcinogens, narrow exposure routes, and restrict the use of safer alternatives under the EU Cosmetics Products Regulation. If Parliament backs the more permissive options, companies could face longer transitional use of carcinogenic and other CMR substances in cosmetics and a harder path to substitution, so regulatory teams should closely track the committee vote and any resulting changes to deadlines and substitution requirements.

15 Apr 2026, 18:25env-health.orgEuropean Union

ECHA Receives CLH Submission for (Benzyloxy)Methanol

Austria submitted a formal proposal to ECHA in March 2026 to classify (benzyloxy)methanol as a Category 1B carcinogen and Category 2 mutagen. This classification would trigger stringent restrictions for biocidal products and mandate hazard labeling for downstream mixtures, impacting market access and formulation strategies.

5 Apr 2026, 05:08echa.europa.euEuropean Union

Canada: Waivers Granted for Certain New-Substance Information Requirements Under CEPA 1999

Canada has issued case-by-case waivers for specific new-substance data requirements, exempting notified substances from certain toxicity and physical-chemical testing. This demonstrates continued regulatory flexibility for market entrants, allowing for reduced compliance costs when specific data is deemed unnecessary for risk assessment.

29 Mar 2026, 17:37gazette.gc.caCanada

European Parliament EMPL Committee To Hold Electronic Vote On Proposal Amending Directive 2004/37/EC

The European Parliament is advancing the sixth revision of the Carcinogens, Mutagens and Reprotoxic Substances Directive toward final interinstitutional negotiations. Businesses should prepare for expanded compliance obligations as the EU moves to establish stricter occupational exposure limits for a broader range of hazardous substances.

28 Mar 2026, 20:35europarl.europa.euEuropean Union

EU SCCS Publishes Minutes of Nanomaterials Working Group Meeting on TiO2 and Synthetic Amorphous Silica

The EU SCCS is advancing safety reviews for titanium dioxide and synthetic amorphous silica in cosmetics while updating nanomaterial guidance. Manufacturers risk the exclusion of specific substance clusters from future approvals or the application of conservative default safety values if data gaps remain unaddressed.

28 Mar 2026, 18:30health.ec.europa.euEuropean Union

EU Commission To Prepare Article 55(3) Derogations For Ethylene Oxide In Archive Protection By June 2026

The European Commission is moving to finalize targeted derogations for ethylene oxide use in cultural heritage preservation by mid-2026. This development underscores the increasingly narrow scope for continued use of this substance, reinforcing the necessity for industry to prioritize alternative solutions across all sectors.

27 Mar 2026, 18:14circabc.europa.euEuropean Union

ECHA Opens Consultation On 54 REACH Testing Proposals (Deadline 8 May 2026)

ECHA has opened a public consultation on 54 new REACH testing proposals for vertebrate studies covering 32 substances including vanadium compounds and petroleum residues. Companies should review existing data and non-animal alternatives by 8 May 2026 to potentially satisfy information requirements and avoid the costs of new animal testing.

27 Mar 2026, 07:00echa.europa.euEuropean Union

EMA Adopts Revised Guideline on the Chemistry of Active Substances for Human Medicines

EMA has finalized revised requirements for the chemistry and manufacture of active substances in human medicines, effective September 2026. Manufacturers must strengthen impurity control strategies and technical justifications for starting materials to ensure compliance with updated safety and quality standards.

26 Mar 2026, 12:25ema.europa.euEuropean Union